38 related articles for article (PubMed ID: 27127130)
21. Frequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinoma.
el-Naggar AK; Lai S; Tucker SA; Clayman GL; Goepfert H; Hong WK; Huff V
Oncogene; 1999 Nov; 18(50):7063-9. PubMed ID: 10597307
[TBL] [Abstract][Full Text] [Related]
22. Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients.
Akervall J; Guo X; Qian CN; Schoumans J; Leeser B; Kort E; Cole A; Resau J; Bradford C; Carey T; Wennerberg J; Anderson H; Tennvall J; Teh BT
Clin Cancer Res; 2004 Dec; 10(24):8204-13. PubMed ID: 15623595
[TBL] [Abstract][Full Text] [Related]
23. Elevated expression of T-lymphoma invasion and metastasis inducing factor 1 in squamous-cell carcinoma of the head and neck and its clinical significance.
Wang S; Li S; Yang X; Yang S; Liu S; Liu B; Liu J
Eur J Cancer; 2014 Jan; 50(2):379-87. PubMed ID: 24189000
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of S100A2 in lymph node metastases of head and neck cancer.
Zhang X; Hunt JL; Shin DM; Chen ZG
Head Neck; 2007 Mar; 29(3):236-43. PubMed ID: 17123307
[TBL] [Abstract][Full Text] [Related]
25. IGF2 DMR0 methylation, loss of imprinting, and patient prognosis in esophageal squamous cell carcinoma.
Murata A; Baba Y; Watanabe M; Shigaki H; Miyake K; Ishimoto T; Iwatsuki M; Iwagami S; Yoshida N; Oki E; Morita M; Nakao M; Baba H
Ann Surg Oncol; 2014 Apr; 21(4):1166-74. PubMed ID: 24318096
[TBL] [Abstract][Full Text] [Related]
26. Altered Expression of Imprinted Genes in Squamous Cell Carcinoma of the Head and Neck.
Hsu CM; Lin PM; Lin HC; Lai CC; Yang CH; Lin SF; Yang MY
Anticancer Res; 2016 May; 36(5):2251-8. PubMed ID: 27127130
[TBL] [Abstract][Full Text] [Related]
27. The mutational spectrum of squamous-cell carcinoma of the head and neck: targetable genetic events and clinical impact.
Mountzios G; Rampias T; Psyrri A
Ann Oncol; 2014 Oct; 25(10):1889-1900. PubMed ID: 24718888
[TBL] [Abstract][Full Text] [Related]
28. Molecular mechanisms of head and neck cancer.
Deshpande AM; Wong DT
Expert Rev Anticancer Ther; 2008 May; 8(5):799-809. PubMed ID: 18471051
[TBL] [Abstract][Full Text] [Related]
29. Genomic screening of head and neck cancer and its implications for therapy planning.
Akervall J
Eur Arch Otorhinolaryngol; 2006 Apr; 263(4):297-304. PubMed ID: 16575584
[TBL] [Abstract][Full Text] [Related]
30. Genomic imprinting in hereditary glomus tumours: evidence for new genetic theory.
van der Mey AG; Maaswinkel-Mooy PD; Cornelisse CJ; Schmidt PH; van de Kamp JJ
Lancet; 1989 Dec; 2(8675):1291-4. PubMed ID: 2574254
[TBL] [Abstract][Full Text] [Related]
31. Regulation and function of the peg3 imprinted domain.
He H; Kim J
Genomics Inform; 2014 Sep; 12(3):105-13. PubMed ID: 25317109
[TBL] [Abstract][Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
